Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INDEX PHARMACEUTICALS

Home Clinical Trial Sponsors and OrganizationsINDEX PHARMACEUTICALS

INDEX PHARMACEUTICALS

FOCAL POINT, Patiala, Punjab, India

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

17

12 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

13

76.5%

Phase 3

2

11.8%

Phase 2

1

5.9%

Trial Status Distribution

Active, not recruiting

12

70.6%

Completed

2

11.8%

Recruiting

1

5.9%

Terminated

1

5.9%

Unknown

1

5.9%

Clinical Trials

Trials sponsored by this organization (17)

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Dec 2022440 participants

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Active, not recruiting

Apr 2022440 participants

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Active, not recruiting

Feb 2022440 participants

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Active, not recruiting

Jan 2022440 participants

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Active, not recruiting

Dec 2021440 participants

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Nov 2021171 participants

A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to Severe Active Left-Sided Ulcerative Colitis

Active, not recruiting

Nov 2021440 participants

Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis

Nov 20216 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials17
Approvals
News

Back to Organizations